Norma Biln has brought strategic and operational execution excellence to each position she has held along her career. Throughout her 24 years in the life sciences she has worked along, built and led teams that have consistently exceeded corporate goals. Norma began her career in clinical research with Pfizer Pharmaceuticals after completing her Bachelor of Science in Physiology at McGill University. She continued her career in several capacities in sales management, marketing and market access with Pfizer Pharmaceuticals, Amgen and Abbott Laboratories. She later joined Stressgen Biotechnologies as Director of Corporate Market Development and Director of Sales and Marketing for Stressgen Bioreagents. Before her role of CEO at Augurex, Norma worked in a senior consulting capacity with Aspreva Pharmaceuticals on Business Development, Commercial and Communications initiatives. Norma holds a Master of Business Administration, is Chair of the Board of Directors of BioTalent Canada and a member of the Board of Directors of Resverlogix Corp (TSX:RVX).
Share this page with your social network and connect on the topics you're passionate about – and get the conversation started.